A GASTRIC RETAINED DOSAGE FORM OF GABAPENTIN

A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. Further, an extended release oral dosage form for releasing gabapentin into the stomach, duodenumans small intestine of the mammal, comprising a cor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOU, SUI YUEN EDDIE, GUSLER, GLORIA M, BERNER, BRET
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. Further, an extended release oral dosage form for releasing gabapentin into the stomach, duodenumans small intestine of the mammal, comprising a core comprising at least 800 mgof gabapentin, surrounded by a semipermeable membrane is described. Se describe un metodo de tratamiento para epilepsia y otros estados de enfermedad que comprende el suministro de gabapentina en una forma de dosificacion gastrica retenida; adicionalmente se describe una forma de dosificacion oral de liberacion extendida para liberar gabapentina en el estomago, duodeno o intestino delgado del mamifero, que comprende un nucleo que comprende por lo menos 800 mg de gabapentina, rodeado por una membrana semipermeable.